First, hypoxia‐triggered release of chemoattractants (i.e., CCL2, CCL5, CXCL12, CSF‐1, and VEGF) from tumor cells and non‐tumor cells to enhance TAMs precursor monocytes recruitment. The gene discussed is CSF1; the disease is neoplasm.